A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB
Year: 2017
Type: article
Source: Annals of Oncology
Authors: J.A. Ajani, A. Udrea, T. Sarosiek, M. Shenker, C. Morgan, J. Pikiel, E. Wojcik, D. Swinson, M. Joseph, A. Luft, T. Salek, C. Tournigand, D. Ferry, Y. Zhang, A. Long, W-L. Kuo, L. Gao, J. Kauh, W. Mansoor
Institutions: The University of Texas MD Anderson Cancer Center, Romanian Institute of Science and Technology, Velindre Cancer Centre, St James's University Hospital, New Cross Hospital, Leningrad Regional Cancer Center, Národný Onkologický Ústav, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Eli Lilly (United States), The Christie Hospital, The Christie NHS Foundation Trust
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2763714874